Join the club for FREE to access the whole archive and other member benefits.

Systolic Blood Pressure Intervention Trial (SPRINT)

2-arm, multicenter, randomized clinical trial

SPRINT is a research study funded by the National Institutes of Health to answer the following question:

"Will lower blood pressure reduce the risk of heart and kidney diseases, stroke, or age-related declines in memory and thinking?"

High blood pressure is a leading cause of death and disability in the US and worldwide. Over 60% of people over age 65 have high blood pressure, and the number of people with high blood pressure is increasing.

More than 9,000 participants will be enrolled into the study at over 90 clinics across the United States and in Puerto Rico. SPRINT participants will be seen regularly by experts in blood pressure management for a period of 4 to 8 years. At the end of the trial, the results of SPRINT will tell us if a lower recommended blood pressure might help to decrease stroke, heart disease, progression of chronic kidney disease, and age-related losses of memory and thinking.

Visit website:

See also: Institute National Institutes of Health (NIH) - Medical research agency that supports scientific studies

Details last updated 09-Mar-2020

Systolic Blood Pressure Intervention Trial (SPRINT) News

Extend life expectancy up to 3 years by aggressively lowering BP

EurekAlert! - 26-Feb-2020

Middle-aged adults at high cardiovascular risk have this chance now based on new study